Another record quarter exemplifying strong growth ahead of market trajectory. The pull back today was a typical reaction really (buy the rumour sell the fact) and imo will be short lived. At the conference call the CEO said he didn't want to sound like a broken record but RMD was growing at twice the market rate (market 20%, RMD 44%). Main competitor Respironics only 17%. With new products in the pipeline for remainder of FY07 he is anticipating continuing strong global growth. And he was very exited about the extremely robust operating cash flow of $35m to take advantage of that strong global growth. I listened to most of the call and was very impressed with how all the questions were answered in great detail. This is a very good company imo selling a very good product and is a great long term growth stock.
1st quarter
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$35.89 |
Change
-0.770(2.10%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $35.95 | $35.99 | $35.49 | $16.10M | 451.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 60 | $35.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $35.90 | 869 | 3 |
View Market Depth
| Last trade - 11.40am 15/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
